183 related articles for article (PubMed ID: 12805559)
1. CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation.
Imadome K; Shirakata M; Shimizu N; Nonoyama S; Yamanashi Y
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7836-40. PubMed ID: 12805559
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival.
Imadome K; Shimizu N; Arai A; Miura O; Watanabe K; Nakamura H; Nonoyama S; Yamamoto K; Fujiwara S
J Infect Dis; 2005 Oct; 192(8):1340-8. PubMed ID: 16170750
[TBL] [Abstract][Full Text] [Related]
3. CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines.
Pokrovskaja K; Ehlin-Henriksson B; Kiss C; Challa A; Gordon J; Gogolak P; Klein G; Szekely L
Int J Cancer; 2002 Jun; 99(5):705-12. PubMed ID: 12115504
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cell growth and Epstein-Barr virus reactivation by CD40 stimulation in Epstein-Barr virus-transformed B cells.
Fukuda M; Satoh TA; Takanashi M; Hirai K; Ohnishi E; Sairenji T
Viral Immunol; 2000; 13(2):215-29. PubMed ID: 10893001
[TBL] [Abstract][Full Text] [Related]
5. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
Martin HJ; Lee JM; Walls D; Hayward SD
J Virol; 2007 Sep; 81(18):9748-58. PubMed ID: 17609264
[TBL] [Abstract][Full Text] [Related]
6. Early events associated with infection of Epstein-Barr virus infection of primary B-cells.
Halder S; Murakami M; Verma SC; Kumar P; Yi F; Robertson ES
PLoS One; 2009 Sep; 4(9):e7214. PubMed ID: 19784370
[TBL] [Abstract][Full Text] [Related]
7. Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1.
Adler B; Schaadt E; Kempkes B; Zimber-Strobl U; Baier B; Bornkamm GW
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):437-42. PubMed ID: 11752411
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus can establish infection in the absence of a classical memory B-cell population.
Conacher M; Callard R; McAulay K; Chapel H; Webster D; Kumararatne D; Chandra A; Spickett G; Hopwood PA; Crawford DH
J Virol; 2005 Sep; 79(17):11128-34. PubMed ID: 16103163
[TBL] [Abstract][Full Text] [Related]
9. Expression profile of nuclear receptors upon Epstein -- Barr virus induced B cell transformation.
Yenamandra SP; Lundin A; Arulampalam V; Yurchenko M; Pettersson S; Klein G; Kashuba E
Exp Oncol; 2009 Jun; 31(2):92-6. PubMed ID: 19550398
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.
Nikiforow S; Bottomly K; Miller G
J Virol; 2001 Apr; 75(8):3740-52. PubMed ID: 11264363
[TBL] [Abstract][Full Text] [Related]
11. CD40 signaling activated by Epstein-Barr virus promotes cell survival and proliferation in gastric carcinoma-derived human epithelial cells.
Imadome K; Shimizu N; Yajima M; Watanabe K; Nakamura H; Takeuchi H; Fujiwara S
Microbes Infect; 2009 Mar; 11(3):429-33. PubMed ID: 19397878
[TBL] [Abstract][Full Text] [Related]
12. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.
Jha HC; Shukla SK; Lu J; Aj MP; Banerjee S; Robertson ES
Oncotarget; 2015 Oct; 6(30):30115-29. PubMed ID: 26336822
[TBL] [Abstract][Full Text] [Related]
14. Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.
Smith N; Tierney R; Wei W; Vockerodt M; Murray PG; Woodman CB; Rowe M
PLoS One; 2013; 8(5):e64868. PubMed ID: 23724103
[TBL] [Abstract][Full Text] [Related]
15. Nuclear receptors and their role in Epstein -- Barr virus induced B cell transformation.
Yenamandra SP; Klein G; Kashuba E
Exp Oncol; 2009 Jun; 31(2):67-73. PubMed ID: 19550394
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes.
Murphy WJ; Funakoshi S; Beckwith M; Rushing SE; Conley DK; Armitage RJ; Fanslow WC; Rager HC; Taub DD; Ruscetti FW
Blood; 1995 Sep; 86(5):1946-53. PubMed ID: 7544649
[TBL] [Abstract][Full Text] [Related]
17. Functions of CD40 and Its Ligand, gp39 (CD40L).
Laman JD; Claassen E; Noelle RJ
Crit Rev Immunol; 2017; 37(2-6):371-420. PubMed ID: 29773027
[TBL] [Abstract][Full Text] [Related]
18. CD19 signalling improves the Epstein-Barr virus-induced immortalization of human B cell.
Hur DY; Lee MH; Kim JW; Kim JH; Shin YK; Rho JK; Kwack KB; Lee WJ; Han BG
Cell Prolif; 2005 Feb; 38(1):35-45. PubMed ID: 15679865
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
Hervé M; Isnardi I; Ng YS; Bussel JB; Ochs HD; Cunningham-Rundles C; Meffre E
J Exp Med; 2007 Jul; 204(7):1583-93. PubMed ID: 17562816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
